FDA Investigator Walter N Lange
Walter N Lange has conducted inspections on 2 sites in 2 countries as of 13 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Germany
FDA Investigators that have inspected at least one site in common with Walter N Lange:
Aimee Cunningham, PhD,
Amy Devlin, PhD,
Anh M Lac,
Anissa M Cheung,
Anita Narula, PhD,
Ann L Demarco,
Arie C Menachem,
Azza Talaat,
Bo Chi, PhD,
Brenda P King,
Brenda W Uratani, PhD,
Brentley S Collins,
Burnell M Henry,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Concepcion Cruz, Jr,
Dawn M Braswell,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Ekaterina Allen,
Eliezar Ramos,
Ellen P Madigan,
Erika V Butler,
Felix Maldonado,
Gene D Arcy,
Gunther Boekhoudt, PhD,
Jee Chung, PhD,
John D White,
Joyce A Rockwell,
Julie D Bringger,
Justine M Corson,
Kalavati Suvarna, PhD,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kevin A Gonzalez,
Kurt A Brorson, PhD,
LCDR Debra Emerson,
Mariza M Jafary,
Mark Brunswick, PhD,
Martha T Olone,
Mary E Storch,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Michael Shanks, MS,
Michelle M Noe Varga,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Monica Commerford, PhD,
Monique C Lo,
Mra Munizn,
Nailing Zhang,
Ogechi C Nna,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Priscilla M Pastrana,
Qing Joanna Zhou, PhD,
Reyes Candau Chacon, PhD,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Richard W Thornton,
Robert J Martin,
Robert Jennings,
Rose Ashley,
Sean R Marcsisin,
Seth A Mailhot,
Stacey S Degarmo,
Thuy T Nguyen, LCDR,
Veronica Fuentes, MS,
Victor J Gangi,
Virgilio F Pacio, CSO,
Wayne E Seifert,
Yanming An, PhD,
Zerita White,
Zhong Li, PhD,
Ziyang Su, PhD
Walter N Lange's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2000 | FDA 483 Response | Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483R, 2000-06-06 |
July, 2003 | FDA 483 Response | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483R, 2004-04-01 |
July, 2003 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2003-07-24 |
May, 2000 | EIR | Boehringer Ingelheim Pharma GmbH and Co. KG - EIR, 2000-07-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more